• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性肺纤维化(IPF)稳定和进展患者的脂质组谱存在可检测的差异。

There is detectable variation in the lipidomic profile between stable and progressive patients with idiopathic pulmonary fibrosis (IPF).

机构信息

Separation Science and Metabolomics Laboratory, Murdoch University, Murdoch, WA, Australia.

School of Biomedical Science, University of Western Australia, Crawley, WA, Australia.

出版信息

Respir Res. 2021 Apr 9;22(1):105. doi: 10.1186/s12931-021-01682-3.

DOI:10.1186/s12931-021-01682-3
PMID:33836757
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8033725/
Abstract

BACKGROUND

Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease characterized by fibrosis and progressive loss of lung function. The pathophysiological pathways involved in IPF are not well understood. Abnormal lipid metabolism has been described in various other chronic lung diseases including asthma and chronic obstructive pulmonary disease (COPD). However, its potential role in IPF pathogenesis remains unclear.

METHODS

In this study, we used ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC-QTOF-MS) to characterize lipid changes in plasma derived from IPF patients with stable and progressive disease. We further applied a data-independent acquisition (DIA) technique called SONAR, to improve the specificity of lipid identification.

RESULTS

Statistical modelling showed variable discrimination between the stable and progressive subjects, revealing differences in the detection of triglycerides (TG) and phosphatidylcholines (PC) between progressors and stable IPF groups, which was further confirmed by mass spectrometry imaging (MSI) in IPF tissue.

CONCLUSION

This is the first study to characterise lipid metabolism between stable and progressive IPF, with results suggesting disparities in the circulating lipidome with disease progression.

摘要

背景

特发性肺纤维化(IPF)是一种以纤维化和进行性肺功能丧失为特征的慢性间质性肺疾病。IPF 涉及的病理生理途径尚不清楚。在包括哮喘和慢性阻塞性肺疾病(COPD)在内的各种其他慢性肺部疾病中,已经描述了异常的脂质代谢。然而,其在 IPF 发病机制中的潜在作用仍不清楚。

方法

在这项研究中,我们使用超高效液相色谱-四极杆飞行时间质谱(UPLC-QTOF-MS)来描述来自 IPF 患者稳定和进行性疾病的血浆中的脂质变化。我们进一步应用了一种称为 SONAR 的非依赖性数据获取(DIA)技术,以提高脂质鉴定的特异性。

结果

统计建模显示稳定和进行性受试者之间存在可变性区分,揭示了进展者和稳定 IPF 组之间甘油三酯(TG)和磷脂酰胆碱(PC)检测的差异,这在 IPF 组织中的质谱成像(MSI)中得到了进一步证实。

结论

这是第一项描述稳定和进行性 IPF 之间脂质代谢的研究,结果表明随着疾病的进展,循环脂质组存在差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b584/8033725/b05bdd277b30/12931_2021_1682_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b584/8033725/4b1e237990d5/12931_2021_1682_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b584/8033725/fe198c6e26cd/12931_2021_1682_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b584/8033725/b05bdd277b30/12931_2021_1682_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b584/8033725/4b1e237990d5/12931_2021_1682_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b584/8033725/fe198c6e26cd/12931_2021_1682_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b584/8033725/b05bdd277b30/12931_2021_1682_Fig3_HTML.jpg

相似文献

1
There is detectable variation in the lipidomic profile between stable and progressive patients with idiopathic pulmonary fibrosis (IPF).特发性肺纤维化(IPF)稳定和进展患者的脂质组谱存在可检测的差异。
Respir Res. 2021 Apr 9;22(1):105. doi: 10.1186/s12931-021-01682-3.
2
Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics.采用脂质组学技术鉴定特发性肺纤维化患者血浆中的脂质生物标志物。
BMC Pulm Med. 2017 Dec 6;17(1):174. doi: 10.1186/s12890-017-0513-4.
3
Untargeted metabolomics of human plasma reveal lipid markers unique to chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.非靶向代谢组学分析人血浆中的脂质标志物可揭示慢性阻塞性肺疾病和特发性肺纤维化的独特性。
Proteomics Clin Appl. 2021 May;15(2-3):e2000039. doi: 10.1002/prca.202000039. Epub 2021 Mar 18.
4
Serum metabolic profiling identified a distinct metabolic signature in patients with idiopathic pulmonary fibrosis - a potential biomarker role for LysoPC.血清代谢组学分析鉴定出特发性肺纤维化患者的独特代谢特征 - LysoPC 可能作为生物标志物。
Respir Res. 2018 Jan 10;19(1):7. doi: 10.1186/s12931-018-0714-2.
5
Lipid metabolism in idiopathic pulmonary fibrosis: From pathogenesis to therapy.特发性肺纤维化中的脂质代谢:从发病机制到治疗。
J Mol Med (Berl). 2023 Aug;101(8):905-915. doi: 10.1007/s00109-023-02336-1. Epub 2023 Jun 8.
6
Analysis of tissue lipidomics and computed tomography pulmonary fat attenuation volume (CT ) in idiopathic pulmonary fibrosis.特发性肺纤维化的组织脂质组学与计算机断层扫描肺脂肪衰减体积(CT)分析
Respirology. 2023 Nov;28(11):1043-1052. doi: 10.1111/resp.14582. Epub 2023 Aug 29.
7
EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis.EMPIRE 注册研究,捷克部分:人口统计学、肺功能和高分辨率计算机断层扫描对特发性肺纤维化患者生存及临床病程的影响
Clin Respir J. 2018 Apr;12(4):1526-1535. doi: 10.1111/crj.12700. Epub 2017 Sep 26.
8
Discovery and validation of extracellular/circulating microRNAs during idiopathic pulmonary fibrosis disease progression.特发性肺纤维化疾病进展过程中细胞外/循环微小RNA的发现与验证
Gene. 2015 May 10;562(1):138-44. doi: 10.1016/j.gene.2015.02.065. Epub 2015 Feb 25.
9
Idiopathic pulmonary fibrosis is associated with increased impedance measures of reflux compared to non-fibrotic disease among pre-lung transplant patients.与肺移植术前的非纤维化疾病患者相比,特发性肺纤维化患者的反流阻抗测量值更高。
Neurogastroenterol Motil. 2015 Sep;27(9):1326-32. doi: 10.1111/nmo.12627. Epub 2015 Jul 14.
10
C-X-C motif chemokine 13 (CXCL13) is a prognostic biomarker of idiopathic pulmonary fibrosis.C-X-C基序趋化因子13(CXCL13)是特发性肺纤维化的一种预后生物标志物。
Am J Respir Crit Care Med. 2014 Apr 15;189(8):966-74. doi: 10.1164/rccm.201309-1592OC.

引用本文的文献

1
The Hypoxia-Retinoid Axis in Idiopathic Pulmonary Fibrosis: Multifaceted Etiology and Therapeutic Potential.特发性肺纤维化中的缺氧-视黄酸轴:多方面的病因及治疗潜力
Int J Mol Sci. 2025 May 31;26(11):5302. doi: 10.3390/ijms26115302.
2
The clinical value of triglyceride to high-density lipoprotein cholesterol ratio for predicting stroke-associated pneumonia after spontaneous intracerebral hemorrhage.甘油三酯与高密度脂蛋白胆固醇比值对预测自发性脑出血后卒中相关性肺炎的临床价值。
BMC Neurol. 2025 Apr 9;25(1):148. doi: 10.1186/s12883-025-04154-z.
3
Influence of metabolic factors on systemic sclerosis complicated with severe interstitial lung disease based on high-resolution computed tomography grading.

本文引用的文献

1
Metabolomic analysis of fibrotic mice combined with public RNA-Seq human lung data reveal potential diagnostic biomarker candidates for lung fibrosis.对纤维化小鼠进行代谢组学分析,并结合公共 RNA-Seq 人类肺部数据,揭示了潜在的用于诊断肺纤维化的生物标志物候选物。
FEBS Open Bio. 2020 Nov;10(11):2427-2436. doi: 10.1002/2211-5463.12982. Epub 2020 Oct 5.
2
Metabolic Dysregulation in Idiopathic Pulmonary Fibrosis.特发性肺纤维化中的代谢失调。
Int J Mol Sci. 2020 Aug 7;21(16):5663. doi: 10.3390/ijms21165663.
3
Tentative identification of 20()-protopanaxadiol metabolites in human plasma and urine using ultra-performance liquid chromatography coupled with triple quadrupole time-of-flight mass spectrometry.
基于高分辨率计算机断层扫描分级的代谢因素对系统性硬化症合并严重间质性肺病的影响
Clin Rheumatol. 2025 Apr;44(4):1617-1624. doi: 10.1007/s10067-025-07305-2. Epub 2025 Feb 15.
4
PPARG/SPP1/CD44 signaling pathway in alveolar macrophages: Mechanisms of lipid dysregulation and therapeutic targets in idiopathic pulmonary fibrosis.肺泡巨噬细胞中的PPARG/SPP1/CD44信号通路:特发性肺纤维化中脂质失调的机制及治疗靶点
Heliyon. 2025 Jan 2;11(1):e41628. doi: 10.1016/j.heliyon.2025.e41628. eCollection 2025 Jan 15.
5
Succinate promotes pulmonary fibrosis through GPR91 and predicts death in idiopathic pulmonary fibrosis.琥珀酸通过 GPR91 促进肺纤维化,并可预测特发性肺纤维化患者的死亡。
Sci Rep. 2024 Jun 22;14(1):14376. doi: 10.1038/s41598-024-64844-5.
6
The novel molecular mechanism of pulmonary fibrosis: insight into lipid metabolism from reanalysis of single-cell RNA-seq databases.肺纤维化的新分子机制:单细胞 RNA-seq 数据库再分析揭示脂质代谢。
Lipids Health Dis. 2024 Apr 3;23(1):98. doi: 10.1186/s12944-024-02062-8.
7
Lipid mediators of inhalation exposure-induced pulmonary toxicity and inflammation.吸入暴露诱导的肺毒性和炎症的脂质介质。
Inhal Toxicol. 2024 Feb;36(2):57-74. doi: 10.1080/08958378.2024.2318389. Epub 2024 Feb 29.
8
Circulating metabolic profile in idiopathic pulmonary fibrosis: data from the IPF-PRO Registry.特发性肺纤维化的循环代谢谱:来自IPF-PRO注册研究的数据。
Respir Res. 2024 Jan 25;25(1):58. doi: 10.1186/s12931-023-02644-7.
9
Novel lipidomes profile and clinical phenotype identified in pneumoconiosis patients.新型脂质组学谱及尘肺患者的临床表型。
J Health Popul Nutr. 2023 Jun 15;42(1):55. doi: 10.1186/s41043-023-00400-7.
10
Role of PPARγ in dyslipidemia and altered pulmonary functioning in mice following ozone exposure.PPARγ 在臭氧暴露后小鼠血脂异常和肺功能改变中的作用。
Toxicol Sci. 2023 Jun 28;194(1):109-119. doi: 10.1093/toxsci/kfad048.
使用超高效液相色谱联用三重四极杆飞行时间质谱法对人血浆和尿液中20()-原人参二醇代谢物进行初步鉴定。
J Ginseng Res. 2019 Oct;43(4):539-549. doi: 10.1016/j.jgr.2018.03.005. Epub 2018 Apr 5.
4
Comparison of Single Phase and Biphasic Extraction Protocols for Lipidomic Studies Using Human Plasma.使用人血浆进行脂质组学研究的单相和双相提取方案比较
Front Neurol. 2019 Aug 21;10:879. doi: 10.3389/fneur.2019.00879. eCollection 2019.
5
Lipid Synthesis Is Required to Resolve Endoplasmic Reticulum Stress and Limit Fibrotic Responses in the Lung.脂质合成对于缓解内质网应激和限制肺部纤维化反应是必需的。
Am J Respir Cell Mol Biol. 2018 Aug;59(2):225-236. doi: 10.1165/rcmb.2017-0340OC.
6
A Lipidomics Approach to Identifying Key Lipid Species Involved in VEGF-Inhibitor Mediated Attenuation of Bleomycin-Induced Pulmonary Fibrosis.一种脂质组学方法用于鉴定参与血管内皮生长因子抑制剂介导的博来霉素诱导的肺纤维化减轻的关键脂质种类。
Proteomics Clin Appl. 2018 May;12(3):e1700086. doi: 10.1002/prca.201700086. Epub 2018 Jan 19.
7
Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics.采用脂质组学技术鉴定特发性肺纤维化患者血浆中的脂质生物标志物。
BMC Pulm Med. 2017 Dec 6;17(1):174. doi: 10.1186/s12890-017-0513-4.
8
Inhibition of Phosphoglycerate Dehydrogenase Attenuates Bleomycin-induced Pulmonary Fibrosis.抑制磷酸甘油酸脱氢酶可减轻博来霉素诱导的肺纤维化。
Am J Respir Cell Mol Biol. 2018 May;58(5):585-593. doi: 10.1165/rcmb.2017-0186OC.
9
Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study.特发性肺纤维化患者结局预测的 52 基因风险特征验证:一项国际多中心队列研究。
Lancet Respir Med. 2017 Nov;5(11):857-868. doi: 10.1016/S2213-2600(17)30349-1. Epub 2017 Sep 21.
10
Scanning Quadrupole Data-Independent Acquisition, Part A: Qualitative and Quantitative Characterization.扫描四极杆数据非依赖性采集,第 A 部分:定性和定量特性描述。
J Proteome Res. 2018 Feb 2;17(2):770-779. doi: 10.1021/acs.jproteome.7b00464. Epub 2017 Dec 29.